News

Month Year

Month Year

Oct 18, 2019

Sanofi to conduct precautionary voluntary recall of Zantac OTC in Canada and the U.S.
- Photos 1
Oct 1, 2019

"Pillars of Strength" photo exhibit opens to celebrate National Seniors Day with compelling images of Canadian Seniors
Sep 27, 2019

Health Canada approves Dupixent™ as the first biologic for the treatment of adolescents with moderate-to-severe atopic dermatitis
Sep 26, 2019

Sanofi Canada receives Gold-Level Parity Certification
- Photos 1
Jun 11, 2019

Canadian employers underestimate the presence of chronic disease in the workforce
Apr 11, 2019

Health Canada issues Notice of Compliance with Conditions (NOC/c) for LibtayoTM (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC)
Oct 17, 2018

Canadians are invited to join the conversation: Raise Your Hand for Diabetes
Oct 1, 2018

Sanofi aims to topple the flu as it marks National Seniors Day with a Guinness World Record attempt
Sep 27, 2018

Canadians living with diabetes in Ontario and Manitoba now have greater access to diabetes medicine
Sep 25, 2018

Health Canada approves Lovenox® for the prevention of blood clot formation in the extra-corporeal circulation during hemodialysis in patients with end stage kidney disease (ESKD)

Studies show that Lovenox® (enoxaparin sodium) is an alternative to conventional heparin in preventing clotting during hemodialysis

Show per page